COVID-19 infection, caused by a new type of virus called SARS-CoV-2, was first seen in WUHAN city of China's Hubei province in December 2019, and then spread rapidly and turned into a worldwide epidemic, that is, a pandemic.
Since it is a new infection, there is limited information about its course in pregnant women, but according to the data we have, no increased susceptibility has been reported in pregnant women. However, the weaker immune system in pregnant women and physiological changes in the circulatory and respiratory systems may lead to the development of more severe infections, as in other viral infections. However, according to the data so far, there is no evidence that pregnant women are more susceptible to COVID-19 transmission or that pregnant women with COVID-19 infection experience more severe lung problems.
The virus is transmitted mostly through droplets, that is, whether the patient is sick or not. However, asymptomatic individuals carrying the virus can be transmitted through contact such as coughing, sneezing, kissing, etc., and the virus can also enter the body from infected (contaminated) surfaces through the hands, mouth, nose and eye mucosa. Therefore, for protection, avoid close contact, maintain 2 meters of social distance, use a protective mask, use hands. General rules such as paying attention to hygiene etc. also apply to pregnant women. The incubation period, that is, the time from the virus entering the body until the clinical symptoms of the disease appear, is on average 5 (2-14) days.
The most common symptoms of the disease are fever, cough and / or respiratory distress. Although it is seen less frequently; Smell and taste disorders, sore throat, headache, nausea, vomiting and diarrhea may also be observed. Along with fever, chills, chills, muscle joint and headaches also accompany the picture.
80% of the patients survive with mild symptoms, severe cases with high lung involvement are on average 15%, respiratory failure and Critical cases with multiple organ involvement are approximately 5% and the mortality rate is between 2.3-5%. These rates are not exact and depend on the possible subtypes of the virus, mutation rate and characteristics of the affected population. may vary.
Diagnosis is made by analyzing secretion samples taken from the upper and/or lower respiratory tract. (PCR method) In suspicious cases where the first test is negative, the test is repeated one day later. Blood is used in the diagnosis. tests and Lung CT (Computed tomography) are also used. When a lung X-ray or CT scan is required in a pregnant patient, the abdominal area should be protected with a lead cover and the patient should be given the necessary informative information and her consent is obtained. According to the data of ARD (American Society of Radiology), a single chest X-ray and The amount of radiation transmitted to the fetus with a single chest CT is within acceptable limits.
COVID-19 management during pregnancy: early patient isolation, effective infection control measures, appropriate drug therapy, oxygen therapy, It requires avoidance of fluid overload, respiratory support in case of progressive respiratory failure, fetal monitoring, individual birth timing and method, and a multidisciplinary team approach that will provide all of these. It does not create any additional risk for -19. In pregnant women with a definitive diagnosis of COVID-19, the treatment scheme recommended by the Ministry of Health is applied.
I wish you all a healthy, peaceful pregnancy away from all risks, not only from COVID-19 I hope..
Read: 0
